Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

PSMA-BCH × Gastrointestinal × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastasis Colon Cancer 1

Interventions

Oxaliplatin 1264 Fluorouracil 1172 Capecitabine 971 Gemcitabine 924 Leucovorin 834 Bevacizumab 739 Irinotecan 730 Cisplatin 593 Radiotherapy 504 Cetuximab 422 pembrolizumab 385 Paclitaxel 353 Drug Therapy 317 Nivolumab 298 130-nm albumin-bound paclitaxel 278 Docetaxel 262 Sorafenib 257 S 1 (combination) 250 Folfox protocol 238 Surgical Procedures, Operative 225 Albumin-Bound Paclitaxel 221 lenvatinib 191 durvalumab 191 apatinib 186 tislelizumab 182 sintilimab 178 regorafenib 175 Radiosurgery 174 Neoadjuvant Therapy 172 Magnetic Resonance Spectroscopy 172

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06935149 2025-04-24

PSMA

Primo Biotechnology Co., Ltd

Phase 1 Not yet recruiting

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡